NewsBenzingaHC Wainwright & Co. Maintains Buy on ORIC Pharmaceuticals, Lowers Price Target to $20 HC Wainwright & Co. Maintains Buy on ORIC Pharmaceuticals, Lowers Price Target to $20 Benzinga 2026.11.19 11:27 (GMT+0) Open on Benzinga Other news Kash Patel Skips House Hearing After Attending Trump’s Mar-a-Lago Gala Offering $50,000 Access to Top Officials, Draws Bipartisan Criticism: Report HC Wainwright & Co. Reiterates Buy on ProMIS Neurosciences, Maintains $18 Price Target HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target Needham Reiterates Buy on Palo Alto Networks, Maintains $425 Price Target BTIG Maintains Buy on Palo Alto Networks, Raises Price Target to $442 'Koenigsegg Stake Sale Values Hyper-car Maker at €1.3 Billion' - Bloomberg
Kash Patel Skips House Hearing After Attending Trump’s Mar-a-Lago Gala Offering $50,000 Access to Top Officials, Draws Bipartisan Criticism: Report